Lmwx 60mg 0.6ml Injection

Lmwx 60mg 0.6ml Injection is a pharmaceutical product containing Enoxaparin Sodium, a low molecular weight heparin (LMWH) that functions as an anticoagulant. This injection is designed to prevent and treat harmful blood clots, playing a critical role in managing thromboembolic disorders.

Administered via subcutaneous injection, Lmwx 60mg 0.6ml is indicated for various clinical applications, including the prophylaxis and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also utilized in the management of acute coronary syndromes, such as unstable angina and non-Q-wave myocardial infarction, and for preventing blood clots following surgical procedures.

Key Features : 

Active Ingredient and Therapeutic Class: Contains Enoxaparin Sodium (60mg/0.6ml), an anticoagulant belonging to the low molecular weight heparin class.
Licensed Indications: Used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), management of acute coronary syndromes, and prophylaxis of blood clots post-surgery.
Storage Conditions: Store at controlled room temperature, between 15°C to 25°C, away from light and moisture. Do not freeze.
Regulatory Approval: Manufactured in WHO-GMP certified facilities, conforming to Indian Pharmacopoeia (IP) standards.